The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium
about
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancerRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseA population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.Cell-mediated immune response to human papillomavirus infection.Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in BrazilDecreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, ChinaImmunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinomaLocal immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.Human papillomavirus molecular biology and pathogenesis.Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian womenRole of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control studyRecent developments in human papillomavirus vaccines.Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review.HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:CThe invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Genetic susceptibility of cervical cancer.Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.Human papillomavirus therapeutic vaccines in head and neck tumors.Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer riskHPV infection: immunological aspects and their utility in future therapyExpression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma.The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.Atopic patients with genital warts have a more protracted clinical course and a greater probability of recurrences.Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.The effect of stopping smoking on cervical Langerhans' cells and lymphocytes.The paradox of IL-10-mediated modulation in cervical cancer.HLA-DRB1*1501 and HLA-DQB1*0301 alleles are positively associated with HPV16 infection-related Kazakh esophageal squamous cell carcinoma in Xinjiang China.High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cells.Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape.
P2860
Q24802483-846FBF15-7BDE-45A1-A72D-4AC102444502Q26996330-49B0179D-840C-47CA-B1CE-3C8145FB66E6Q27302754-536498F2-EE7A-4ABE-88AE-93DE80441CE7Q33574329-0996ABD2-7FA7-4AC0-883D-8B06F3BDFD5AQ33829192-12E2683F-9E53-4418-A310-E4C735914BA5Q33998922-368F1259-C094-4E81-B975-AB2D1EAC98F8Q34041963-F68CCEFE-0717-454D-B34B-7401EC3E947FQ34142861-8423A15C-AFF9-45E8-B3B0-B15600856545Q34371662-E21CF969-DC80-403E-BD72-C2926450AB58Q34469904-DF9DFE77-094F-4CF4-8F5B-C6D42836C5A2Q34480019-DE518179-B201-4A10-A0A2-ED71B215F17CQ34546550-38926103-C7D6-4F52-B8F9-A010A7F4E0BDQ34796393-BC7690D6-DF66-4507-8B53-A63D71D55A71Q35135255-229CF468-AE0D-45EA-965C-9207EC628932Q35614701-635911ED-5BC6-4896-9A89-91A5871FE5E8Q35842528-5A20AED9-4CB2-4CF6-A8BA-ED5A024A87FCQ36114379-35EAD65D-33D8-4376-A3B5-304843F53E2DQ36215782-49766226-4D99-4E78-A76E-228A9EEDA79AQ36315857-96B87F49-E7F4-49CF-B7A0-E70987E4E3A6Q36541450-FD2E2B1A-7A2E-429B-B7B1-955570F17D1DQ36683202-6F693DDC-D051-4D05-AF29-DE21E478F3C3Q36794745-E424DA7E-459F-4E1F-A16D-75DE21701AA8Q36817148-DF2BF637-79B0-403B-A56C-38C62EA39476Q37143508-845E1FC7-B220-4EBA-BDF8-ED2D8F02B961Q37145093-A4BE7EC6-3CF6-4E22-92F5-5DFACC1FA97DQ37213884-54BF9A34-F278-42B3-AC9E-FC7D3B690922Q37329072-3D432826-F6D9-41C0-A87C-3B3C9EB9233FQ37380005-0DF587BA-2735-4ECA-A1D1-D0F526064351Q38600163-00B1C4A2-A48C-4CD9-BE5A-A6ECDD5963AEQ40341281-45552943-2921-4490-BC21-B219E816C6D0Q40359015-E00F3F24-DE88-41F4-8028-C33CAE9FA73AQ40430288-9854F220-382F-4A29-BBEA-D50A8AE2B692Q40715963-8C913F7D-6172-43A4-AF82-5AA15CE89B1FQ42571106-FEDD9722-381D-4935-A93E-A3D54FD1AEBDQ44036788-CC472E28-F305-4A3D-A4F5-A8FAA4E24E09Q45420696-2CCED6BF-ED7F-40EF-88B4-4B2B627C84F3Q46434837-233988AF-29D7-482B-A4CF-6770FFCD3A4EQ47609322-52B6E033-6A5D-4164-977C-E49138098959Q53395274-D7011396-BB45-4978-8275-FE315D94C90CQ54515558-8D346E84-B64C-41FB-9021-E92F21A05666
P2860
The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The antigen-presenting environ ...... emalignant cervical epithelium
@ast
The antigen-presenting environ ...... emalignant cervical epithelium
@en
The antigen-presenting environ ...... emalignant cervical epithelium
@nl
type
label
The antigen-presenting environ ...... emalignant cervical epithelium
@ast
The antigen-presenting environ ...... emalignant cervical epithelium
@en
The antigen-presenting environ ...... emalignant cervical epithelium
@nl
prefLabel
The antigen-presenting environ ...... emalignant cervical epithelium
@ast
The antigen-presenting environ ...... emalignant cervical epithelium
@en
The antigen-presenting environ ...... emalignant cervical epithelium
@nl
P2093
P2860
P1476
The antigen-presenting environ ...... emalignant cervical epithelium
@en
P2093
P2860
P356
10.1046/J.1365-2249.1999.00826.X
P577
1999-04-01T00:00:00Z